|
1. Amgen drug under FDA review in wake of 8 deaths Full story
2. The medications most at risk amid Iran war-driven supply threats Full story
3. Health IT is moving fast — and so are Becker's reviewer opportunities. Apply for a complimentary event badge & join 2,500+ exec peers here.
4. Yale researchers study GLP-1's potential for SUD Full story
5. FDA approves 1st weekly basal insulin for Type 2 diabetes Full story
6. Static reports fall short for multispecialty RCM. See what's next here.
7. FTC nears settlement with CVS Caremark Full story
8. 13 potential benefits of GLP-1s: Report Full story
Becker's Learning Opportunities
9. Can IT and care management improve together? This case study says yes. See it here.
10. How 3 leading systems coordinate care for a complex, recurring heart condition here.
11. AHA shares how to launch + sustain a telehealth stroke program here.
12. Interested in more? See Becker’s full lineup of
webinars and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
